Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban in Sickle Cell Disease
NCT02179177Phase 3Terminated
- Sponsor
- AkiraBio
- Start
- Jan 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in sickle cell disease (SCD), sponsored by AkiraBio. Started Jan 2015; status: terminated.
02
Drugs
apixaban
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02179177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02179177.